CS logo
small CS logo
Special hospital for Internal diseases, Oncomed system

Belgrade, Serbia
Doctor in Belgrade
Karpoševa 91, Beograd

About Special hospital for Internal diseases, Oncomed system


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Special hospital for Internal diseases, Oncomed system


During the past decade, Special hospital for Internal diseases, Oncomed system conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Special hospital for Internal diseases, Oncomed system" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Special hospital for Internal diseases, Oncomed system


According to Clinical.Site data, the most researched conditions in "Special hospital for Internal diseases, Oncomed system" are "Crohn's Disease" (2 trials), "Colitis, Ulcerative" (1 trials), "Crohn Disease" (1 trials), "Lung Cancer" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Special hospital for Internal diseases, Oncomed system" in a lesser frequency.

Clinical Trials Intervention Types at Special hospital for Internal diseases, Oncomed system


Most popular intervention types in "Special hospital for Internal diseases, Oncomed system" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (3 trials), "Golimumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Special hospital for Internal diseases, Oncomed system


The vast majority of trials in "Special hospital for Internal diseases, Oncomed system" are 7 trials for "All" genders.

Clinical Trials Status at Special hospital for Internal diseases, Oncomed system


Currently, there are NaN active trials in "Special hospital for Internal diseases, Oncomed system". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Special hospital for Internal diseases, Oncomed system, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Special hospital for Internal diseases, Oncomed system, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".